Coordinating global capabilities to support a gene therapy targeting a rare neurodegenerative disorder

An emerging biotech company was searching for an experienced partner to help their early-phase efforts to advance a gene therapy that targeted a rare neurodegenerative disease. Learn how multiple teams across Labcorp collaborated to support the biotech's successful IND with GLP toxicology and biodistribution study and CMC services for the sponsor's unique program.